GET THE APP
Lung Cancer Biomarker Journals | Open Access Journals
Journal of Clinical Case Reports

Journal of Clinical Case Reports

ISSN: 2165-7920

Open Access
Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil
Submit Manuscript arrow_forward arrow_forward ..

Lung Cancer Biomarker Journals

Lung cancer is the most common cause of cancer mortality worldwide, accounting for 25% of all cancer deaths with an incidence rate of 1.2 million people per year.The main risk factor of lung cancer is smoking; the risk of lung cancer is tenfold higher in smokers than in non-smokers. Lung cancer can typically be grouped into two large categories: small-cell lung cancer  and non-smallcell lung cancer , which account for  of lung cancers, respectively. The discovery of cancer biomarkers, specific molecules that help to distinguish between normal and cancerous conditions, may potentially be used to develop a more effective diagnostic tool for lung cancer. Cancer biomarkers consist of either of genetic materials or proteins because cancer is a heterogeneous disease that reflects gene and protein changes within a cancer cell. However, proteins are the main functional units of biological processes. Almost all of the Food and Drug Administration (FDA)-approved cancer biomarkers are protein markers.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Clinical Sciences

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report
Citations: 1345

Journal of Clinical Case Reports received 1345 citations as per Google Scholar report

Citation image
Journal of Clinical Case Reports peer review process verified at publons
Publon image

Indexed In

Related Links

PMC/PubMed Indexed Articles
Rituximab as First-Line Therapy in Severe Lupus Erythematosus with Neuropsychiatric and Renal Involvement: A Case-Report and Review of the Literature
 

Open Access Journals

arrow_upward arrow_upward